Alto Neuroscience, Inc. (ANRO) Corporate Subsidiaries
Alto Neuroscience, Inc. (ANRO) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ANRO
CIK: 1999480
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerRobert Perry
Audit LocationChicago, Illinois, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-02 | FORM 4 | 0002009130-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-29 | FORM 4 | 0002009130-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-09-29 | — | 144 Filing | 0001950047-26-009858 | View SEC Doc Filr Page |
| 8-K | 2026-08-27 | 2026-08-26 | 8-K | 0001999480-26-000024 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352632 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003498 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005199 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001999480-26-000023 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001999480-26-000022 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002170 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-20 | — | SCHEDULE 13G Filing | 0000935836-26-000361 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-13 | FORM 8-K | 0001104659-26-083274 | View SEC Doc Filr Page |
| 424B5 | 2026-07-14 | — | 424B5 | 0001104659-26-083268 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-13 | FORM 8-K | 0001104659-26-082875 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | FORM 4 | 0001777760-26-000016 | View SEC Doc Filr Page |
| 3 | 2026-05-29 | 2026-05-27 | FORM 3 | 0001777760-26-000015 | View SEC Doc Filr Page |
| 8-K | 2026-05-28 | 2026-05-27 | 8-K | 0001999480-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-05-15 | 2026-05-14 | FORM 4 | 0002007795-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000902664-26-002550 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000919574-26-003456 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001831942-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000919574-26-003214 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0001830326-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0002008212-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0002009654-26-000004 | View SEC Doc Filr Page |